EFSA acknowledges potential of GOS in FSMP applications
The opinion, ‘Safety of the extension of use of galactooligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283’, was published on 30 March 2022